PHYSICIAN-LED HEALTHCARE ADVISORY
Make Your Healthcare Innovation Believable
The best idea doesn't always win. The most believable one does. And your strategy is your story.
When clinical strategy, regulatory pathway, evidence, product risk, adoption, and commercial logic fail to align, even promising innovations become difficult to believe.
Robert N. Bilkovski, MD, MBA · Founder, RNB Ventures Consulting
LEADERSHIP & ADVISORY EXPERIENCE
Abbott • GE Healthcare • Hospira / Pfizer • Takeda • Olympus • Philips • QIAGEN • Avanos
The physician behind the practice
Robert N. Bilkovski, MD, MBA
Physician · Healthcare Strategist
Founder, RNB Ventures Consulting
Dr. Robert Bilkovski (Dr. Bob) has watched promising healthcare technologies stall and die, and it almost never comes down to the science. An emergency physician turned fractional Chief Medical Officer, he approaches innovation like clinical triage: find the fatal flaw before it becomes fatal.
That instinct was sharpened through medical leadership roles at Abbott, GE Healthcare, Hospira, and others, more than 30 clinical trials across pharma, devices, and diagnostics, and his current seat as CMO for a company whose drug makes brain tumors glow during surgery. He is the author of Make Your Story Believable.
WHERE TO START
Three ways in
Meet the physician behind the practice, explore the thinking in the book, or see how RNB Ventures helps healthcare innovators decide.
01 Authority
Meet the physician-executive behind RNB Ventures.
02 The Book
Explore the ideas behind Make Your Story Believable.
03 Services
See how RNB Ventures helps healthcare innovators.
THE BELIEVABILITY LAB
Where ideas are engineered for trust.
"The problem is often not the innovation itself. It is the gap between what the organization believes about its innovation and what its audiences are willing to believe."
Your strategy is your story. When clinical relevance, evidence, regulatory strategy, adoption, and commercial logic stop aligning, credibility begins to break down. The 10-Point Believability Diagnostic helps identify where those gaps may be hiding, before investors, regulators, clinicians, customers, or partners find them first.
- 1 Problem Credibility
- 2 Audience Clarity
- 3 Clinical Relevance
- 4 Evidence Strength
- 5 Regulatory Credibility
- 6 Adoption & Economics
- 7 Differentiation
- 8 Narrative Coherence
- 9 Messenger Credibility
- 10 Execution Readiness
SERVICES
Physician-led advisory
Designed to help healthcare innovators make better decisions, reduce risk, and build strategies that withstand scrutiny.
Strategic Medical & Clinical Advisory
Senior physician-led guidance across clinical development, medical affairs, evidence strategy, regulatory alignment, and commercialization.
Medical Product Safety & Recall Advisory
Independent physician support for HHEs, recalls, product risk, FDA-related matters, and counsel-directed engagements.
Executive Workshops & Speaking
Keynotes, workshops, and executive programs that help healthcare leaders recognize and close critical Believability Gaps.
The Believability Lab
A strategic framework for identifying where clinical, regulatory, evidence, adoption, and commercial strategy fall out of alignment, and credibility begins to break down.
Investor & Portfolio Advisory
Clinical and strategic diligence that helps investors, boards, and portfolio companies identify risks before they become consequential.
Clinical Communications & Media Strategy
Helping companies translate complex medical concepts into clear, credible communications for healthcare professionals and public audiences.
THE BOOK
Why do so many promising medical device startups fail?
It's not the science. It's the story. In Make Your Story Believable, Dr. Bilkovski draws on two decades in emergency medicine, Fortune 500 companies, and the chaos of startup life to diagnose why promising healthcare ventures crash, and how yours doesn't have to.
PRAISE
What readers and leaders say
On Make Your Story Believable and the thinking behind RNB Ventures.
Find the gaps before your stakeholders do.
For organizations facing important clinical, regulatory, financing, or commercialization decisions, a conversation is the place to start.